Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Internet Explorer is no longer a supported browser.

This website may not display properly with Internet Explorer. For the best experience, please use a more recent browser such as the latest versions of Google Chrome, Microsoft Edge, and/or Mozilla Firefox. Thank you.

Your Environment. Your Health.

Progress Reports: Michigan State University: TCDD Impedes the Minimal Activation Threshold Required for Initiation of B Cell Differentiation: An Integrated Experimental and Computational Modeling Approach

Superfund Research Program

TCDD Impedes the Minimal Activation Threshold Required for Initiation of B Cell Differentiation: An Integrated Experimental and Computational Modeling Approach

Project Leader: Norbert E. Kaminski
Grant Number: P42ES004911
Funding Period: 2000-2020
View this project in the NIH Research Portfolio Online Reporting Tools (RePORT)

Learn More About the Grantee

Visit the grantee's eNewsletter page Visit the grantee's eNewsletter page

Progress Reports

Year:   2019  2018  2017  2016  2015  2014  2013  2012  2011  2010  2009  2008  2007  July 2006  Jan 2006  2005  2004  2003  2002  2001  2000 

Suppression of antibody responses is a hallmark of exposure to dioxin-like compounds. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is the most toxic member of this family of environmental contaminants. Studies in laboratory animals by project researchers have shown that B lymphocytes, a type of white blood cell responsible for producing protective antibodies against pathogens, is significantly impaired by TCDD treatment. Mechanistic studies demonstrated a specific type of protein, termed a kinase, to be responsible for altered antibody secretion. These experiments led to the identification of a population of human B cells termed innate-like B cells that exhibit significant sensitivity to suppression by TCDD. The researchers also demonstrated that a protein called interferon gamma can reverse the effects of TCDD on B cells.

In addition, in collaboration with Center investigators, project researchers previously demonstrated that activated carbon (AC) may be a highly effective and inexpensive material for remediating environmental contamination of dioxins. Dioxins bind very tightly to AC blocking intestinal absorption and toxicity while not disrupting the microorganisms that populate the intestine, compared to administrated TCDD orally to mice. In most recent investigations, the researchers show that three commercially available ACs, representing a wide range of pore size distributions, were equally effective in eliminating the bioavailability of TCDD.

Last, collaborative work with investigators specializing in mathematical modeling of biological responses led to a new understanding of the mechanisms by which TCDD alters liver function and this approach will now be applied to B cells using new technologies termed single cell RNA sequencing.

to Top